Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical Guideline

The use of animals in research requires careful ethical consideration of whether the burden on the animals is justified. As one important part of the project evaluation, a harm–benefit analysis (HBA) must be carried out in order to approve projects in line with the EU Directive 2010/63/EU. This impl...

Full description

Bibliographic Details
Main Authors: Anne Zintzsch, Elena Noe, Herwig Grimm
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/10/5/857
_version_ 1797567874292776960
author Anne Zintzsch
Elena Noe
Herwig Grimm
author_facet Anne Zintzsch
Elena Noe
Herwig Grimm
author_sort Anne Zintzsch
collection DOAJ
description The use of animals in research requires careful ethical consideration of whether the burden on the animals is justified. As one important part of the project evaluation, a harm–benefit analysis (HBA) must be carried out in order to approve projects in line with the EU Directive 2010/63/EU. This implies that harms and benefits must be assessed prospectively beforehand in order to weigh them. Although there are different methods of weighing, it is clear that an assessment of prospective harms and benefits is a precondition for any weighing procedure. In this context, projects that use genetically altered (GA) lines raise new issues. A unique challenge when using GA lines is the significant lack of knowledge in this context, making it difficult and sometimes impossible to estimate harm prospectively with sufficient certainty, since it is not predictable what sort of harm—if at all—the animals are going to experience. Therefore, this contribution aims to deal with the challenges of harm assessment in GA animals and their implications for welfare assessment and the HBA. A practical guideline is presented herein to serve as guidance for relevant harm factors and address the main challenges, particularly when dealing with uncertainties in the process of HBA.
first_indexed 2024-03-10T19:48:35Z
format Article
id doaj.art-56f523527e904960b3df0aae4cc5289a
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-10T19:48:35Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-56f523527e904960b3df0aae4cc5289a2023-11-20T00:34:47ZengMDPI AGAnimals2076-26152020-05-0110585710.3390/ani10050857Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical GuidelineAnne Zintzsch0Elena Noe1Herwig Grimm2Institute of Laboratory Animal Science, University of Veterinary Medicine Vienna, 1210 Vienna, AustriaMesserli Research Institute, University of Veterinary Medicine Vienna, Medical University Vienna, University Vienna, 1010 Vienna, AustriaMesserli Research Institute, University of Veterinary Medicine Vienna, Medical University Vienna, University Vienna, 1010 Vienna, AustriaThe use of animals in research requires careful ethical consideration of whether the burden on the animals is justified. As one important part of the project evaluation, a harm–benefit analysis (HBA) must be carried out in order to approve projects in line with the EU Directive 2010/63/EU. This implies that harms and benefits must be assessed prospectively beforehand in order to weigh them. Although there are different methods of weighing, it is clear that an assessment of prospective harms and benefits is a precondition for any weighing procedure. In this context, projects that use genetically altered (GA) lines raise new issues. A unique challenge when using GA lines is the significant lack of knowledge in this context, making it difficult and sometimes impossible to estimate harm prospectively with sufficient certainty, since it is not predictable what sort of harm—if at all—the animals are going to experience. Therefore, this contribution aims to deal with the challenges of harm assessment in GA animals and their implications for welfare assessment and the HBA. A practical guideline is presented herein to serve as guidance for relevant harm factors and address the main challenges, particularly when dealing with uncertainties in the process of HBA.https://www.mdpi.com/2076-2615/10/5/857genetically altered animalswelfare assessmentuncertaintyseverity classificationharm-benefit analysis3RsAGENT
spellingShingle Anne Zintzsch
Elena Noe
Herwig Grimm
Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical Guideline
Animals
genetically altered animals
welfare assessment
uncertainty
severity classification
harm-benefit analysis
3RsAGENT
title Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical Guideline
title_full Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical Guideline
title_fullStr Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical Guideline
title_full_unstemmed Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical Guideline
title_short Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly—A Practical Guideline
title_sort navigating uncertainties how to assess welfare and harm in genetically altered animals responsibly a practical guideline
topic genetically altered animals
welfare assessment
uncertainty
severity classification
harm-benefit analysis
3RsAGENT
url https://www.mdpi.com/2076-2615/10/5/857
work_keys_str_mv AT annezintzsch navigatinguncertaintieshowtoassesswelfareandharmingeneticallyalteredanimalsresponsiblyapracticalguideline
AT elenanoe navigatinguncertaintieshowtoassesswelfareandharmingeneticallyalteredanimalsresponsiblyapracticalguideline
AT herwiggrimm navigatinguncertaintieshowtoassesswelfareandharmingeneticallyalteredanimalsresponsiblyapracticalguideline